Filana Therapeutics (FLNA) Share-based Compensation (2010 - 2026)
Filana Therapeutics' Share-based Compensation came in at $4.07 million for Q2 2026, down 11.1% from $4.58 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Filana Therapeutics (FLNA) Share-based Compensation (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Filana Therapeutics reported Share-based Compensation of $17.92 million, down 15.3% year-over-year; for FY2025, it came in at $19.58 million, up 20.2% from FY2024.
- Share-based Compensation has increased in each of the last five years, with a five-year compound annual growth rate of 81.7% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $16.29 million in FY2024 (+255.2%), $4.59 million in FY2023 (+122.0%), $2.07 million in FY2022 (+17.5%) and $1.76 million in FY2021 (+78.0%).
- The five-year range for quarterly Share-based Compensation is $470,000 (Q3 2022) to $5.74 million (Q4 2024).
- Year-over-year, Share-based Compensation has declined for four consecutive quarters, with growth averaging 99.9% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q3 2024 (growth of 490.9%), and the weakest in Q1 2026 (a decline of 22.1%).
- Business Quant data shows FLNA's Share-based Compensation at $4.07 million (Q1 2026), $5.37 million (Q4 2025) and $4.4 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Filana Therapeutics | 32.11 Mn | -338.73 Mn | - | 4.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.07 Mn |
| Mar 31, 2026 | 4.07 Mn |
| Dec 31, 2025 | 5.37 Mn |
| Sep 30, 2025 | 4.40 Mn |
| Jun 30, 2025 | 4.58 Mn |
| Mar 31, 2025 | 5.23 Mn |
| Dec 31, 2024 | 5.74 Mn |
| Sep 30, 2024 | 5.61 Mn |
| Jun 30, 2024 | 2.60 Mn |
| Mar 31, 2024 | 2.34 Mn |
| Dec 31, 2023 | 2.13 Mn |
| Sep 30, 2023 | 949,000.00 |
| Jun 30, 2023 | 835,000.00 |
| Mar 31, 2023 | 673,000.00 |
| Dec 31, 2022 | 616,000.00 |
| Sep 30, 2022 | 469,000.00 |
| Jun 30, 2022 | 485,000.00 |
| Mar 31, 2022 | 24,000.00 |
| Dec 31, 2021 | 522,000.00 |
| Sep 30, 2021 | 572,000.00 |
API Access
Filana Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=FLNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "FLNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=FLNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();